CareDx does one thing better than almost any company in diagnostics right now: it charges more per test every quarter…
Category: Newsletters
Bayer’s New Stroke Drug Is Approved. Is That Enough to Buy the Stock?
Three years ago, Bayer’s asundexian program nearly died in a courtroom of clinical data. The Phase 3 atrial fibrillation trial,…
A Democratic Congress Could Mean New Policies. Is Your Retirement Ready?
A note from our friends at Reagan Gold Group_SS(ad) The 401(k) Move Most Americans Don’t Know About Your 401(k) provider…
150 years ago, they built a secret Europe…
A note from our friends at The Agora Companies(ad) Back in the 1860s, settlers from France, Italy, and Germany built…
Socialists win big… Dr. Ron Paul warns what comes next
A note from our friends at MarketWise(ad) Dear Reader, The Democratic Socialists won big at the polls this election cycle.…
1,800 Points in a Day (The Slow Loss Is Worse)
A note from our friends at Decentralized Masters(ad) Dear Reader, The votes are counted. And whoever you voted for… one…
Bloom Energy Is Down 40% From Its High. Q3 Revenue Jumped 138%.
Last week, Bloom Energy (NYSE: BE) signed a 900-megawatt supply agreement with NTT DATA for onsite fuel cell power across…
D-Wave Has $503 Million in Cash and $4.5 Million in Revenue
D-Wave Quantum (Nasdaq: QBTS) reported Q3 2026 revenue of $4.51 million on November 10, up 21% year over year, beating…
Jensen Huang: Elon’s $119 Billion Plan Will Be “Extremely Hard”
A note from our friends at Brownstone Research(ad) Editor’s Note: Former $900 million hedge-fund manager Larry Benedict completed 20 consecutive…
“SpaceX Royalty” Payouts – Next Nov. 18
A note from our friends at The Oxford Club(ad) Hello, my name is Marc Lichtenfeld. And thanks to an obscure…
